TY  - CHAP
M1  - Book, Section
TI  - Management of Pregnant Women and Newborns With Sickle Cell Disease
A1  - Oppong, Samuel A.
A1  - Stewart, Jodi-Anne
A1  - DeBaun, Michael R.
A2  - Gladwin, Mark T.
A2  - Kato, Gregory J.
A2  - Novelli, Enrico M.
PY  - 2021
T2  - Sickle Cell Disease
AB  - Pregnant  women  with  sickle  cell  disease  experience  significant  morbidity  and  mortality  compared  to  the  general  population  in  both  low-middle  and  high-income  settings.  Women  with  sickle  cell  disease  are  more  likely  to  experience  hypertensive  emergencies  (preeclampsia  and  eclampsia),  intrauterine  growth  restriction  (IUGR),  low  birth  weight,  fetal  demise,  venous  thromboembolism,  peripartum  cardiomyopathy,  and  maternal  death  when  compared  to  age-matched  healthy  pregnant  women  in  both  low-middle–  and  high-income  settings.1-5  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/20
UR  - hemonc.mhmedical.com/content.aspx?aid=1179342711
ER  -